InvestorsHub Logo
Post# of 251721
Next 10
Followers 44
Posts 4530
Boards Moderated 0
Alias Born 07/19/2006

Re: investorgold2002 post# 119215

Monday, 05/02/2011 8:06:58 PM

Monday, May 02, 2011 8:06:58 PM

Post# of 251721
re Xa/IIa activity

is responsible for an important and well-established
mechanism of action that explains, in significant part, the pharmacological activity for LMWHs



this issue has been discussed on this board before if you do a search. i agree with you that biomarkers that exist for copaxone don't quite measure up to "explaining to a significant degree the pharmacological activity" of the compound, and one is going to have to put more weight on the characterization relative to lovenox. nevertheless Xa/IIa don't fully explain the activity of LMW heparins either, and the biomarkers of copaxone do have some correlation with activity and some are even used by TEVA as manufacturing controls, so it is all relative and a question of degree

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.